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ABSTRACT PAGE 
 
 
Dopamine (DA) contributes to critical functions in the central nervous system. By introducing 
electrical stimulation in vivo at the rat’s medial forebrain bundle, evoked DA signals can be 
measured at a carbon fiber electrode with fast scan cyclic voltammetry (FSCV) in rat’s dorsal 
striatum. Previously, evidence suggested that the heterogeneity in evoked DA responses reflects 
the difference in inherent kinetics, which might play an important role physiologically.  
A restricted diffusion based numerical model produced great fit between simulations and 
observed responses for stimulation lengths no longer than 3 seconds, using 4 or sometimes 3 
adjustable parameters. A study was designed to explore different supra-physiological stimuli and 
examine these evoked responses in the dorsal striatum after raclopride, a D2 antagonist drug, was 
given. The effects of raclopride were different based on the kinetic heterogeneity, and a refined 
DA kinetic model was used to model the responses up to stimulation lengths of 10 seconds. 
Based on the new model, it seems that the domains are different in autoinhibitory tone, which 
derives from different basal DA concentration required to activate the D2 receptors.  
The parameters can be used to generate delivery and clearance curves that represent the 
DA being delivered to and cleared from the electrode at each time point. Often, multiple 
parameters sets will produce good fits to individual evoked responses. In these cases, however, 
the multiple parameter sets generate similar delivery and clearance curves. For this reason, we 
conclude that delivery and clearance curves provide an effective tool for investigating the kinetic 
properties of DA systems.  
Adrian C. Michael 
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1.0  INTRODUCTION 
1.1 NIGROSTRIATAL DOPAMINE PATHWAY 
Dopamine (DA) is one of the most important neurotransmitters in the central nervous system 
(CNS). DA contributes to many critical functions such as reward mechanisms, learning and 
motor control (Double and Crocker, 1995; Reynolds et al., 2001; Schultz, 2002). Any type of 
abnormality in the DA system could lead to disorders including schizophrenia, Parkinson’s 
disease and drug addiction (Grace, 1995; Lotharius et al., 2002; Pappatà et al., 2008).  
In the nigrostriatal pathway, the cell body of DA neuron is in the substantia nigra, where 
it extends its axon through medial forebrain bundle (MFB) and terminates in the striatum (Carr 
and White, 1986; Horvitz, 2000). The neurons usually maintain a voltage difference across the 
cell’s membrane, with a resting potential lower than the potential of extracellular space. When a 
synaptic input causes the potential to rise above the threshold, an action potential is produced by 
voltage gated ion channels. This causes the sodium (Na+) channels to open and allow Na+ to flow 
into the cell, following by potassium (K+) channels opening which allow K+ to flow out and 
create an outward current. The influx of Na+ depolarizes the cell while the efflux of K+ 
repolarizes the cell, bringing the membrane potential back to its resting potential (Nelson, 2004). 
Upon the arrival of an action potential, the calcium ion (Ca2+) channels are opened, causing an 
increase in the Ca2+ concentration inside the cell (Ceccarelli and Hurlbut, 1980). The influx of 
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Ca2+ causes the vesicles containing dopamine to fuse to presynaptic cell membrane and release 
dopamine into synaptic gap with calcium ions acting as a second messenger.  
DA is synthesized first by converting L-tyrosine to L-3,4-dihydroxyphenylalanine (L-
DOPA) and then from L-DOPA into DA by DOPA decarboxylase (Elsworth and Roth, 1997). 
Once synthesized, it is then packaged into vesicles. The interaction between DA and the targeted 
protein receptors allows the presynaptic neuron to communicate with the postsynaptic cell. These 
receptors are G-protein coupled receptors (GPCR) made up of seven alpha helices that span 
throughout the cell membrane. When DA is bound on their extracellular side, the receptor 
changes its conformation in the cytoplasmic side and alters the binding affinity of the G-protein 
to the receptor. After DA is bound to the receptor, the G-protein complex dissociates from the 
receptor. There are two main types of DA receptors; D1-like receptors activate adenylate cyclase 
(AC) and increase intracellular levels of cyclic adenosine monophosphate (cAMP) while D2-like 
receptors inhibit AC and decrease the production of cAMP (Onali et al., 1985; Missale et al., 
1998; Ford, 2014). The postsynaptic cells contain both D1 and D2-like receptors and the 
presynaptic terminals only have D2-like receptors (Delle Donne et al., 1997). DA released from 
neuron terminals elevates the extracellular DA concentration activating the receptor protein.  
Clearance of DA is accomplished via the dopamine transporter (DAT) (Benoit-Marand et 
al., 2000; Salahpour et al., 2008). It is an integral membrane protein symporter that removes DA 
back to the cytosol by coupling its movement with Na+/K+ ATPase. By co-transporting two Na+ 
ions and one Cl- ion, the created ion concentration gradient allows the reuptake of DA (Torres et 
al., 2003). DAT decreases the extracellular DA concentration, terminating the activation of the 
transmembrane receptor proteins.  
. 
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1.2 IN VIVO ELECTROCHEMICAL DETECTION OF DOPAMINE 
Dopamine is an electroactive catecholamine with two hydroxyl groups on the benzene ring. DA 
can be oxidized by removing two electrons and two protons, converting into dopamine-o-
quinone (DAQ) (Figure 1). The process is reversible, which allows DAQ to be reduced to DA by 
adding back two electrons and two protons. However, since the oxidation and reduction of the 
two electrons and two protons are occuring as four separate events, there are six possible 
pathways known as the nine-member box (Wipf et al., 1986). Because the oxidation and 
reduction go through different pathways, the separation of oxidation and reduction peaks is 
larger than the 29.5 mV predicted by the ideal reversible reaction (Bard and Faulkner, 2001). 
Micro carbon fiber electrodes (CFE) are most commonly used for DA detection (Figure 
2). The CFE is 5-7 m in diameter so it is small enough to minimize tissue damage while 
sampling in vivo (Jaquins-Gerstl and Michael, 2009) and allows high spatial resolution (Kile et 
al., 2012).  The small surface area of the electrode limits the number of terminals from which it 
samples. Thus, the CFE measures DA responses from a discrete population of terminals unlike 
microdialysis, another sampling technique (Michael et al., 2005; Nesbitt et al., 2013). The CFE 
has a high sensitivity to the change in DA concentration and has a detection limit in the nM 
ranges.  
The potential required for the oxidation-reduction reaction depends on the scan rate; the 
voltammogram contains information such as shape of the curve, peak height and peak separation 
that can serve as the “fingerprint” of the analyte. Also, the magnitude of the current can be 
converted to the change in concentration via a simple calibration curve. Due to these properties, 
an incredible amount of information can be gathered from fast scan cyclic voltammetry (FSCV). 
With a scan rate of 400 V/s, FSCV is able to complete the 3 V scan in 7.5 ms (Figure 3), giving  
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it sub-second temporal resolution (Missale et al., 1998; Bath et al., 2000). The fast scan rate also 
eliminates other interference that has similar oxidation and reduction potentials to DA because 
those reactions are slower. Taken together, FSCV with CFE detection is capable of detecting 
sub-second, high nM concentration changes from a small population of neurons in vivo.  
However, FSCV method is not suitable to measure the baseline concentration of an 
analyte. The main source of the total signal is from the non-faradaic charging current caused by 
the fast scan rate. Furthremore, the amplitude of the background current depends on the 
experimental setup, buffer solution and electrode. Therefore, it is impossible to measure DA 
from a single FSCV voltammogram; at least a background scan before the DA concentration 
changes and a scan following the change are both required (Figure 4). Because of the large 
charging current, FSCV is used to measure the change in DA concentration instead of its basal 
level. The magnitude of change is independent to the baseline DA concentration present within 
the limits of detection. 
 
 
  
 
Figure 1 Oxidation and reduction process of dopamine. 
Dopamine is being oxidized to dopamine-o-quinone and being reduced back to dopamine. This reversible reaction 
involves 2 electrons and 2 protons and is governed by the nine-member box scheme (Wipf et al., 1986).  
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Figure 2 Electron microscopy image of carbon fiber microelectrode. 
The carbon fiber electrode is around 5-7 m in diameter and is cut to the length of 250 m. The 
glass capillary is pulled to a tight tip around the carbon fiber then sealed with slurry epoxy to 
secure it. 
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Figure 3 Fast scan cyclic voltammetry scan. 
The potential was held at 0 V, ramping up to 1 V at a scan rate of 400 V/s, scanning down to -0.5 
V, and back to 0 V versus Ag/AgCl. The entire scan was finished within 7.5 ms, which gives 
sub-second temporal resolution. Red line is where oxidation reaction happens and green line is 
where reduction happens.  
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Figure 4 Cyclic voltammogram of fast scan cyclic voltammetry.  
Before (left) and after (right) background subtraction. Charging current (black line) contributes to the major part of 
to the total signal (red line). Therefore, the background should be subtracted in order to see the current generated due 
to the change in DA.   
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2.0  METHOD AND MATERIAL 
2.1 VOLTAMMETRY 
Borosilicate capillaries (0.58 mm I.D., 1.0 mm O.D., Sutter Instruments, Novato, CA) were 
soaked in acetone overnight. Carbon fiber electrodes were made by pulling cleaned and dried 
glass capillaries to sharp tips around a single carbon fiber (7 m in diameter, T650, Cytec 
Carbon Fibers LLC., Piedmont, SC) with a vertical glass puller (Narishige, Tokyo, Japan). The 
tips were sealed with Spurr Epoxy (Polysciences Inc., Warrington, PA) and cured in oven at 70 
ºC overnight. Carbon fibers extending from the seal were trimmed under the microscope to 250 
m in length. Microelectrodes were pre-treated by soaking the tip in isopropyl alcohol (Sigma 
Aldrich, St. Louis, MO) containing activated carbon powder (Fisher Scientific, Pittsburgh, PA) 
for at least 30 minutes prior to the experiment.  
FSCV was performed with a computer controlled potentiostat (EI-400, Ensman 
Instruments, Bloomington, IN) and CV Tarheels software (Version 4.3, courtesy of Dr. Michael 
Heien, University of Arizona, Tucson, AZ). The potential was held at a resting potential of 0 V, 
ramped at a scan rate of 400 V/s from 0 V to 1 V, down to -0.5 V and back to 0 V versus a 
Ag/AgCl reference electrode. Scans were performed at 10 Hz (Figure 5). Dopamine 
voltammograms were obtained by background subtraction. 
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Figure 5 FSCV waveform and stimulus pulses. 
The FSCV waveform and stimulus pulse are offset in time so they do not overlap. The waveform is applied at a 
frequency of 10 Hz. The stimulus is a 2 ms biphasic pulse with pulse height of 250 A at a frequency of 60 Hz by 
optically isolated stimulus boxes.  
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2.2 ELECTRODE CALIBRATION 
The electrodes are calibrated in vitro to establish the relationship between current and DA 
concentration. The calibration is both carried out pre- and post-experiment in a flow cell with 
gravity fed nitrogen purged artificial cerebral spinal fluid (aCSF: 152 mM Cl-, 145 mM Na+, 2.7 
mM K+, 1.2 mM Ca+, 2.0 mM phosphate, pH 7.4). Standards for calibration were prepared by 
dissolving dopamine hydrochloride (Sigma Aldrich, St. Louis, MO) in aCSF. Conversion of in 
vivo oxidation currents to DA concentration conversion was based on post-calibration results.  
2.3 ANIMALS AND SURGICAL PROCEDURES 
All in vivo animal procedures were performed under approval of the Institutional Animal Care 
and Use of Committee (IACUC) of the University of Pittsburgh. Male Sprague-Dawley rats 
(250-350 g) (Charles River, Raleigh, NC) were intubated then anesthetized with isoflurane (2% 
by volume, Baxter Healthcare, Deerfield, IL) and placed in a stereotaxic frame (David Kopf 
Instruments, Tujunga, CA) and wrapped in a heating blanket (Harvard Apparatus, Holliston, MA) 
that kept the body temperature at 37 C. The scalp was shaved and the skull was exposed. Three 
holes were drilled through the skull. The dura was carefully removed to expose the brain. The 
incisor bar was adjusted so that the dorsal ventral measurements at lambda and bregma were no 
more than 0.01 mm apart (flat skull).  
Electrical connection between the brain and the reference electrode was established by 
creating a salt bridge with a Kimwipe soaked in aCSF held together with a plastic pipette tip. A 
carbon fiber microelectrode was placed in the ipsilateral striatum (from bregma: 3.8 mm lateral, 
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0.2 mm anterior, 4.5 mm below dura) using a stereoscope to avoid hitting any surface blood 
vessels. A bipolar, stainless steel stimulating electrode (MS 303-1-untwisted, Plastics One, 
Roanoke, VA) was lowered into the ipsilateral medial forebrain bundle (MFB, from midline: 1.2 
mm lateral, from bregma: 4.3 mm posterior, 7.2 mm below dura). The final position was set by 
lowering the microelectrode until evoked DA release was observed in the striatum. The relative 
positions can be seen in figure 6 and figure 7. 
 
 
 
 
Figure 6 Relative positions looking from the top. 
The relative potions of reference electrode, carbon fiber electrode and stimulating electrode relative to bregma. 
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Figure 7 Sagittal view of the experimental setup. 
The reference electrode is placed in contact with the brain, the working electrode is placed in striatum, and the 
stimulating electrode is lowered into the MFB. 
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3.0  INTRODUCTION AND MOTIVATION 
3.1 THE HETEROGENEITY OF DOPAMINE RESPONSES 
The long-known explanation of heterogeniety of DA releases has been attributed to the 
difference in terminal density in the striatum. It was thought that some recording sites are closer 
to the electrode (Garris et al., 1994). The hypothesis suggests that different gap sizes between the 
terminals and the electrode result from differing terminal desnities. For responses that require 
stimulations longer than 0.2s to be observed, it implied that  DA has to diffuse across the larger 
gap between the terminals and the electrodes for the signal to be detected.  As a result, it has 
been common practice  to optimize the position of CFE to sites with high population of DA 
terminals for the responses to be seen quickly upon stimulation. The non-optimized responses 
have been concluded to the electrode being in an area away from DA terminals (Peters and 
Michael, 2000). 
However, we were able to demonstrate that the heterogeneity of dopamine responses is 
due to kinetics (Moquin and Michael, 2009). The responses were widely separated into fast and 
slow responses (Figure 8). Fast sites respond immediately to stimulation, as little as 0.2 seconds, 
while it can take longer than 0.2 seconds for slow sites to respond (Moquin and Michael, 2009). 
Fast sites can be further categorized into four subtypes. In short, type 1 fast sites are linear for the 
entire duration of stimulus, type 2 increase continuously but not in a linear fashion, type 3 do not 
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increase during the entire stimulation and are non-linear, and type 4 are biphasic. The fast sites 
being focused in this entire document are type 4 responses because this type of responses reveal 
the simultaneous detection of DA from terminals exhibiting heterogeneous behaviors within one 
single recording. This is also why type 4 responses are usually referred as hybrid responses 
(Figure 9).  
Fast and slow sites responses respond differently to D2 antagonists. It is hypothesized 
that the slow responses result from autoinhibition, which exists prior to the stimulus, presumably 
due to basal DA in the extracellular space being sufficient to activate the pre-synaptic D2 
receptors (Usiello et al., 2000; Benoit-Marand et al., 2001; Kita et al., 2007). Raclopride, a D2 
antagonist, increases evoked DA release upon prolonged electrical stimulation (longer than 200 
ms) but does not effect responses from short stimuli (1~4 pulses at 60Hz) (Garris et al., 1994). 
The absense of an effect on brief stimulus responses implies a minimal of autoinhibition for fast 
sites. 
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Figure 8 Fast and slow type evoked responses. 
In Fast sites, DA is detected immediately upon the first 0.2 s of stimulation while slow sites require longer than 0.2 s 
for DA to be detected (left, 0.2 s stimulation length). Slow site responses can be detected with longer stimulation 
(right, 3 s stimulation length). Circles indicate the start of the stimulation and triangles indicate the end of 
stimulation.  
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Figure 9 The five dorsal striatum responses.  
Fast site responses are categorized into 4 types, where type 4 is also called a hybrid type. The square is the start of 
stimulus and triangles are the ends of the stimulus. Solid lines are the average of responses and dotted lines are the 
SEMs (Figure taken from Taylor et al., 2015). 
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3.2 MODELING THE IN VIVO DOPAMINE KINETICS 
The Diffusion Gap (DG) model was the reigning explanation of the heterogeneous kinetics of 
DA. This model proposes that there is a physical gap between the DA terminal and the recording 
site (Wightman et al., 1988). The theory proposed that the slow response was the effect of CFE 
placed a certain distance from the DA terminals. During an electrical stimulation, DA is 
immediately released but it requires some time to diffuse to the electrode, which causes a delay 
in the signal (Venton et al., 2003). This hypothesis implies that the slow responses are caused by 
experimental errors and poor choice of recording sites (Wu et al., 2001).  
However, there are several problems with this model. For example, a lag happens when 
the response doesn’t immediately take off upon stimulation and an overshoot happens when the 
signal continues to rise even after the stimulus ends. According to this model, response with lag 
should be accompanied with overshoot, but this is not always the case. The duration of lag and 
overshoot should be the same, however this is not always observed. In addition, raclopride can 
eliminate the delay in the onset of the DA signal observed in a slow site. There cannot be a 
physical gap between the recording site and the DA terminals because pharmacological 
conditions should not change the physical properties of the space.  
An alternate explanation was introduced by our lab based on the concept of restricted 
diffusion (RD). The original RD model can be represented by equations 1 and 2 (Walters et al., 
2014): 
 
Equation 1 
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Equation 2 
Where this mechanism hypothesizes that DA molecules cannot diffuse freely throughout 
the extracellular space. The extracellular space is divided into an inner compartment (IC) and an 
outer compartment (OC) space to describe the delay in the DA transport. DA is released per 
stimulus pulse, Rp, from axon terminals to the IC then transported to the electrode via a first 
order transport rate kT. DA is detected in the OC by FSCV and the uptake from the OC back to 
the vesicles can be represented by first order rate kU. The detected DA concentration is 
represented by the term  with  as the volume of the OC and  as the stimulation 
frequency.  
A fourth parameter kR was introduced as an exponential release modulator as it better 
represents the curvature of increase in amplitude during the stimulus in both fast and slow sites 
(Walters et al., 2015). The refined four parameter RD model is shown below (Walters et al., 
2015): 
 
Equation 3 
The addition of kR allows the responses to be more accurately reproduced with the model. 
It reflects the data better than a constant addition of DA. By modeling responses obtained with 
high-pulse stimuli, the RD model reveals new information about the kinetics of the fast and slow 
kinetic domains (Walters et al., 2014, 2015, 2016).  
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Figure 10 Restricted diffusion (RD) model. 
A constant amount of DA is released per stimulus pulse by Rp from the axon terminals to the inner compartment 
(IC). DA is then transported at a first order rate kT to the outer compartment (OC), where the DA is detected by the 
electrode. At last, DA in the outer compartment is removed by a first order uptake rate kU back to the terminals. The 
release of DA is modulated by kR (which is not portrayed in this figure). 
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3.3 BI-EXPONENTIAL MODEL—5 PARAMETERS 
The RD model is not sufficient to describe stimulations of longer length, illustrated in figure 
3.4(a) as a 10 second, 60 Hz stimulation. In these cases, the DA concentration does not increase 
during the entire length of the stimulation; it increases to a certain degree then starts to decrease 
until the stimulus ends. In this specific case, a fifth parameter, , is also used to modulate DA 
release into the inner compartment as follows: 
 
Equation 4 
Where DAic is the amount of DA in moles in the inner compartment, Rp is the moles of 
DA released per stimulus pulse, kR1 and kR2 are first-order rate constants that modulates DA 
release over time, and kT is the first-order transport rate constant. f is the stimulus frequency, 
which is held constant. This equation, a modified version of the inner compartment component 
of the RD model equation described above, is referred to here as the biexponential version of the 
RD model. As shown in figure 3.4, the bi-exponential model can reproduce data from longer 
stimulations much more accurately (r2 > 0.9994) than the four parameter RD model (r2 > 
0.9931). The bi-exponential model allows longer responses, up to 20 seconds, to be fitted. With 
the bi-exponential model, we can further study the slow components of evoked responses that 
were long neglected. 
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(A) 
 
(B) 
 
Figure 11 (A) RD model fit (B) Bi-exponential model fit. 
The evoked responses (frequency = 60 Hz, stimulation length = 10 seconds) are averaged of n=7 slow site rats in 
both cases with model fits. SEMs neglected for sake of clarity. The bi-exponential model can produce a much better 
fit.  
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3.4 MOTIVATION 
Previously, our lab’s findings suggested that there are different tonic basal DA concentrations 
present in extracellular space. This supports the idea that the slow domains are due to a sufficient 
pre-stimulus DA concentration which activates the pre-synaptic D2 autoreceptors, however this 
phenomena is absent in fast domains (Moquin and Michael, 2009; Wang et al., 2010). Such 
different results are due to the heterogeneity of the evoked DA kinetics. While autoinhibition can 
be caused by pre-stimulus DA concentrations, it can also be caused by long stimulation lengths 
resulting in post-stimulus autoinhibition. However, at present, it is unclear if such differences are 
caused by pre-stimulus autoinhibition because we were not able to model longer evoked DA 
responses. Therefore, the goal of this study was to examine DA responses in both domains with 
the new bi-exponential model to verify that pre-stimulus autoinhibition is the main contributor to 
difference in fast and slow type responses. 
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4.0  RESULT AND DISCUSSION 
4.1 KINETIC MODELING: BI-EXPONENTIAL (5 PARAMETERS) 
We could fit evoked DA responses in both fast sites and slow sites with the bi-exponential model. 
We administered raclopride, recorded predrug and postdrug responses at stimulation length of 10 
seconds, and applied hang-up correction. Each response is averaged (n=6 fast sites, n=7 slow 
sites). Figure 12 (A) shows that both predrug and postdrug data sets can each be modeled with a 
single set of parameters. The slow site postdrug response has both a higher DA maximum 
concentration and faster release rate when compared to the slow site predrug response. This 
agrees with the known effect of raclopride; it abolishes the slow component, making slow 
response looks more like fast response.  
In the case of fast domain (Figure 12 (B), while the postdrug response fits very well, the 
model underestimates the initial fast component of the predrug response. This corresponds to our 
previous findings that the parameters of the best model fit depends greatly on the fast and slow 
components of a single evoked DA response, and we can model the initial fast component 
individually as well (Walters et al., 2014). As the duration of the stimulation increases, the 
kinetic parameters shift more towards the major component in a single response, which is the 
slow component in this case. Figure 12 (B) demonstrated that the bi-exponential model fit is 
closer in agreement to the slow component and the parameters are demonstrated in table 1. 
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   (A)                   (B) 
 
Figure 12 (A) Slow site and (B) fast site 10 seconds bi-exponential model fit. 
SEMs omitted for clarity. Fast site n=6, slow site n=7. 
 
 
 
Table 1. The parameters of bi-exponential model fit to 10 second data in fast and slow sites. 
 
 
Parameter Slow, 10s pre Slow, 10s post Fast, 10s pre Fast, 10s post 
Rp (mol) 5.10E-21 4.56E-21 1.72E-20 3.56E-21 
kT (s-1) 1.16 0.881 0.881 1.09 
kU (s-1) 1.17 0.874 1.65 1.09 
kR1 (s-1) 0.084 0.072 0.092 0.053 
kR2 (s-1) 0.632 18535 0.197 48.828 
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4.2 KINETIC HETEROGENEITY IN DIFFERENT SITES 
The RD model is sufficient to fit 1 second and 3 seconds evoked responses. The relative fits and 
responses of slow type can be seen in figure 13 while fast type can be seen in figure 14. In both 
types of responses, the values of kT do not have a set value, but we chose to report the parameter 
sets with kT value ranges among 1-2. According to our previous report (Walters et al., 2015), the 
DA is being transported from the terminal to the electrode recording site at the same rate in both 
fast and slow domains and should not be changed based on pharmaceutical conditions. In other 
words, the difference between fast and slow domains are due to the kinetic effect instead of the 
physical space. However, the model has no ability to determine whether the rate determining step 
is transport or uptake and therefore the values are not within a range. This will be discussed in 
the later chapters.  
Since raclopride makes slow type responses look more like fast type responses by 
increasing the initial release as well as the maximum DA concentration, the release per pulse 
parameter should be larger after the administration of raclopride. However, changes in 
parameters Rp and kU between postdrug and predrug are not consistent in both fast and slow 
responses. This contradicts to what we observe in the evoked responses. The release per pulse 
parameter is coupled with the first order uptake rate because when one increases or decreases the 
other parameter responds in the same fashion. Moreover, the uptake occurs throughout the whole 
evoked response when DA is present. Therefore, looking at the parameters themselves is no 
longer sufficient; it is necessary to look at evoked responses in another way. The bi-exponential 
model is not only a more accurate way to fit longer responses, it also provides access to new 
information for both fast and slow components in one single evoked response. 
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Figure 13 Slow site 1 second and 3 seconds evoked responses with RD model fits. 
Average of n=7, SEMs omitted for clarity. T=0 s for start of the stimulus and triangles are the ends of the stimulus.  
 
 
 
Table 2 The parameters of the RD model fit to the slow site 1 second and 3 seconds’ data. 
Parameter Slow, 1s pre Slow, 1s post Slow, 3s pre Slow, 3s post 
Rp (mol) 3.82E-21 2.98E-21 2.97E-21 4.65E-21 
kT (s-1) 1.84 1.54 1.00 1.09 
kU (s-1) 21.46 3.53 5.37 1.09 
kR (s-1) -1.40 -1.49 -0.53 -0.020 
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Figure 14 Fast site 1 second and 3 seconds evoked responses with RD model fits.  
Average of n=6, SEMs omitted for clarity. t=0 s for start of the stimulus and triangles are the ends of the stimulus. 
The initial fast components of predrug overlap with the initial fast components of postdrug responses.  
 
 
 
Table 3 The parameters of the RD model fit to the fast site 1 second and 3 seconds’ data. 
Parameter Fast, 1s pre Fast, 1s post Fast, 3s pre Slow, 3s post 
Rp (mol) 2.57E-21 3.30E-21 1.50E-21 3.31E-21 
kT (s-1) 2.79 1.85 1.76 1.24 
kU (s-1) 6.55 4.29 3.80 1.24 
kR (s-1) -0.38 -1.05 -0.35 -0.063 
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5.0  DELIVERY AND CLEARANCE CURVE 
5.1 INTRODUCTION 
The RD model uses first order kinetics to describe the rate of mass transport to the electrode and 
the rate of uptake from the electrode. As a result, the amount of DA delivered to and cleared 
from the area around the electrode depends on the concentration of DA in the inner and outer 
compartments. Therefore, we will compare the cumulative effect of the parameters, rather the 
individual parameters themselves. To this end, we calculated delivery (Equation 10) and 
clearance (Equation 11) plots with implementation of finite elements. The RD model can be 
expressed as the result of DA being simultaneously added to and removed from the area around 
the electrode: 
Implementing finite element from the RD mathematical model: 
 
Equation 5 
 
 
Equation 6 
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Equation 7 
 
 
Equation 8 
 
The measured dopamine concentration can be represented as : 
 
Equation 9 
 
 
Equation 10 
 
 
Equation 11 
 
Where [DA]delivered is the concentration of DA that reaches the outer compartment, 
[DA]cleared is the concentration of DA that is removed from the outer compartment, kU is the first 
order uptake parameter, and [DA]OC is the concentration of DA in the outer compartment. t is a 
fixed small time element, R is the amount of DA released and T is the amount of DA 
transported to the outer compartment. These are used to evaluate the RD model by a finite 
element process. Data recorded in vivo was evaluated with the RD model as discussed 
previously using the number of parameters indicated, and the kinetic parameters from the best 
fits were used to construct the delivery and clearance curves.  
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5.2 DELIVERY AND CLEARANCE CHANGES OVER TIME 
Fast-type responses exhibit an initially fast response to stimulation (within 0.2 seconds) that over 
time begins to slow. With the bi-exponential RD model and delivery and clearance curves as 
tools, we chose to investigate the origins of the fast-initial component of fast sites in detail. 
Stimulations of various lengths (180 pulses and 600 pulses, at 60 Hz) were applied, the responses 
were modeled with the bi-exponential RD model, and delivery curves were plotted. 
As shown in figure 15 (A), in fast sites the delivery of both before and after raclopride 
increase immediately upon stimulation, except for the 10 second pre-drug stimulation. In this 
case, since the bulk of the stimulation is made up of the slow component, the model “ignores” 
the fast component to fit the bulk of the signal, underestimating the beginning of the curve 
(figure 12 (B) to minimize the sum of squared residuals (SSR). The beginning of the delivery 
curve reflects this underestimation. For the 3 second pre-drug and post-drug stimulations, the 
initial delivery of the first milliseconds remains the same, verifying that D2 antagonist has 
minimal effect to the fast component (Figure 12 (A).  
Slow-type responses prior to drug administration tend to have the characteristic initial 
response delay in 3 and 10 second stimulations. After raclopride, however, this delay is 
eliminated, and DA is immediately delivered to the electrode. The slow site kinetics of DA 
delivery after raclopride exhibit characteristics of fast-type responses, confirming that 
differential activation of D2 receptors in fast and slow kinetic domains prior to stimulus onset is 
responsible for the varying responses to the stimulation. 
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Figure 15 Delivery curves of 3 second and 10 second stimulations. 
Before drug administration and post-raclopride in A) fast sites (n=6) and B) slow sites (n=7). 
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5.3 MULTIPLE PARAMETER SETS 
In some cases, there are multiple equally good parameter sets to describe one single response, 
which can be verified by SSR and R2 value. Based on the delivery and clearance curves created 
by different number of parameter sets, the responses can be categorized into 3 different types, 
which is discussed as follow. 
The type A response has the simplest feature. As shown in figure 16 and figure 18, with 
linear rise during release and exponential fall after stimulation ends, it can be described with 3 
parameters (Rp, kT = kU, kR). In this specific case, with only 2 parameters (Rp, kT = kU) the model 
could produce either equally good fit with identical (Figure 17) or very close (Figure 19) 
delivery and clearance. Usually, there is only 1 best fit in this type of responses, with some 
occasions there are other “okay” fits.   
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Figure 16 Delivery curves of slow-type 3 seconds stimulation after raclopride administration. 
Left: showing the average response and 3-parameter fit. Right: showing the relative delivery and clearance curves. 
(3 parameter: n=7, Rp =4.65E-21, kU = kT = 1, kR = -0.02, r2 > 0.9994) 
 
 
 
 
Figure 17 Delivery curves of slow-type 3 seconds stimulation after raclopride administration. 
Left: showing both 2-parameter and 3-parameter versions create equally good fits. Right: showing the relative 
delivery and clearance curves overlap as well (2 parameter: n=7, Rp = 4.78E-21, kU = kT = 0.99, r2>0.9994) 
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Figure 18 Delivery curves of fast-type 3 seconds stimulation after raclopride administration. 
Left: showing the average response and 3-parameter fit.  
Right: showing the relative delivery and clearance curves. (3 parameter: n=6, Rp =3.31E-21, kU = kT = 1.24, kR = -
0.063, r2 > 0.9999) 
 
 
 
 
Figure 19 Delivery curves of slow-type 3 seconds stimulation after raclopride administration. 
Left: showing both 2-parameter and 3-parameter versions create equally good fits.  
Right: showing the relative delivery and clearance curves are very close (2 parameter: n=6, Rp = 3.56E-21, kU = kT = 
1.20, r2>0.9997) 
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The restricted diffusion model can produce two adjustable parameter sets in some 
responses, we categorize these responses as type B. The two parameter sets have interchangeable 
numerical values of kT and kU with identical value of kR. Since Rp parameter tracks kU, these two 
parameters would increase or decrease together. In this case, the model can produce identical fits 
when faster release is paired with slower transport and when slower release is paired with faster 
transport. The model cannot identify which is the rate-determining step. In this type of responses, 
the features are still relatively simpler with non-linear rise and exponential fall. While there are 
two best fits, based on the difference in parameter values, the delivery and clearance curves are 
different (Figure 20, figure 21 and figure 22). 
 
 
 
 
Figure 20 Delivery curves of fast-type 3 seconds stimulation. 
Left: interchangeable numerical values of kT and kU versions create equally good fits.  
Right:  delivery and clearance curves of two best fits. (n=6, Green: Rp = 1.50E-21, kU = 3.80, kT = 1.76, kR = -0.346, 
r2 > 0.9977; Blue: Rp = 6.94E-22, kU = 1.76, kT = 3.80, kR = -0.346, r2 > 0.9977) 
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Figure 21 Delivery curves of fast-type 1 second stimulation. 
Left: showing interchangeable numerical values of kT and kU versions create equally good fits. Right: delivery and 
clearance curves of two best fits. (n=6, 1: Green: Rp = 6.57E-21, kU = 6.55, kT = 2.79, kR = -0.379, r2 > 0.9963; Blue: 
Rp = 1.12E-21, kU = 2.79, kT = 6.40, kR = -0.339, r2 > 0.9969) 
 
 
 
 
Figure 22 Delivery curves of fast-type 1 second stimulation after raclopride administration. 
Left: showing interchangeable numerical values of kT and kU versions create equally good fits. Right: delivery and 
clearance curves of two best fits. (n=6, Green: Rp = 3.30E-21, kU = 4.29, kT = 1.85, kR = -1.055, r2 > 0.9993; Blue: Rp 
= 1.62E-21, kU = 2.04, kT = 3.62, kR = -0.99, r2 > 0.9994) 
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Because of its complex features containing non-linear rise and peaking during the 
stimulation instead of at the end of the stimulation, as well as the exponential fall, type C 
responses need 4 sometimes 5 variable parameters. Usually, responses with 10 seconds and 
longer stimulation lengths belong to this category and have 1 or more than 1 fits. With more 
parameters, we are capable of fitting more complex responses. Raclopride can eliminate the 
unneeded parameter because it can change slow type component to fast type, making the feature 
simpler. For example, in figure 23 and figure 25, we can tell that the extra parameter is not 
necessary. The kR1 value of the bi-exponential version has the same value as the 4-parameter 
version. With kR2 being such big number, the second release term of equation 3 would be zero. 
However, one should be cautious since the fits would lose their uniqueness. With a simpler 
feature, there can be more “best fits” to a certain evoked response. Therefore, our next step 
should be using the delivery and clearance curves to further interpret the necessity of increasing 
the total number of variable parameters.   
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Figure 23 Delivery curves of fast-type 10 second stimulation after raclopride administration. 
Left: showing both 4 or 5 parameters (in this case 3 or 4 parameters because kU = kT) create equally good fits.  
Right: delivery and clearance curves of two best fits. (n=6, Green: Rp = 3.56E-21, kU = kT = 1.09, kR1 = 0.053, kR2 = 
48.83, r2 > 0.9992; Blue: Rp = 3.50E-21, kU = kT = 1.07, kR = 0.054, r2 > 0.9992) 
 
 
 
 
Figure 24 Delivery curves of fast-type 10 second stimulation. 
Left: the only fit and requires 5 parameters. Right: delivery and clearance curves of the fit. (n=6, Rp = 1.72E-20, kU 
= 1.65, kT = 0.88, kR1 = 0.092, kR2 = 0.197, r2 > 0.9976) 
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Figure 25 Delivery curves of slow-type 10 second stimulation after raclopride administration. 
Left: showing both 4 or 5 parameters create equally good fits. Right: delivery and clearance curves of two best fits. 
(n=7, Green: Rp = 4.56E-21, kU = kT = 0.88, kR1 = 0.072, kR2 = 18535, r2 > 0.9995; Blue: Rp = 4.57E-21, kU = kT = 
0.88, kR = 0.072, r2 > 0.9995) 
 
 
 
 
Figure 26 Delivery curves of slow-type 10 second stimulation. 
Left: the only fit and requires 5 parameters. Right: delivery and clearance curves of the fit. (n=7, Rp = 5.10E-21, kU 
= kT = 1.17, kR1 = 0.084, kR2 = 0.63, r2 > 0.9995) 
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6.0  FUTURE DIRECTION 
6.1 INVESTIGATE OTHER NEUROTRANSMITTERS 
The bi-exponential model depicts the evoked dopamine responses well by being able to replicate 
the two-part release process. With this powerful tool in hand, we can study many other 
neurotransmitters in the central nervous system such as serotonin. In recent years, the possibility 
that serotonin acting in concert with DA contributes to schizophrenia and the action of 
antipsychotic drugs have received increasing attention (Adler et al., 1999; Howes and Kapur, 
2009). The fact that a lot of anti-psychotic and anti-depression drugs are D2 antagonists makes 
studying this matter essential.  
6.2 MODEL RESPONSES AT NEAR NEURON FIRING FREQUENCY 
The stimulations being introduced in this document is at 60 Hz which is super-physiological. We 
would like to study responses at 30 Hz or even 15 Hz since the natural neuron burst firing rate is 
around 20 Hz (Cragg and Rice, 2004). With a combination of the bi-exponential model, delivery 
and clearance, we might be able to understand neuronal DA signals at rates closer to neuron 
firing, which can provide us with a physiologically-meaningful explanation of dopaminergic 
systems.  
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